Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Air Pollutants | 33 | 2011 | 2844 | 2.060 |
Why?
|
Particulate Matter | 27 | 2011 | 2559 | 1.890 |
Why?
|
Germany | 39 | 2012 | 873 | 1.240 |
Why?
|
Environmental Monitoring | 17 | 2011 | 1441 | 1.200 |
Why?
|
Air Pollution | 15 | 2011 | 2317 | 1.130 |
Why?
|
Particle Size | 30 | 2011 | 1644 | 1.110 |
Why?
|
Fibrinogen | 9 | 2011 | 887 | 1.080 |
Why?
|
Inhalation Exposure | 9 | 2011 | 429 | 0.950 |
Why?
|
Myocardial Infarction | 24 | 2011 | 11890 | 0.840 |
Why?
|
Urban Health | 6 | 2011 | 533 | 0.750 |
Why?
|
Vehicle Emissions | 6 | 2011 | 653 | 0.660 |
Why?
|
Respiratory Tract Diseases | 6 | 2011 | 748 | 0.650 |
Why?
|
C-Reactive Protein | 13 | 2010 | 3839 | 0.640 |
Why?
|
Environmental Exposure | 13 | 2011 | 4412 | 0.580 |
Why?
|
Mortality | 6 | 2011 | 2916 | 0.530 |
Why?
|
Polymorphism, Single Nucleotide | 30 | 2012 | 15790 | 0.520 |
Why?
|
Heart Rate | 9 | 2011 | 4180 | 0.510 |
Why?
|
Interleukin-6 | 7 | 2010 | 3215 | 0.480 |
Why?
|
Arrhythmias, Cardiac | 4 | 2012 | 2255 | 0.400 |
Why?
|
Survivors | 6 | 2010 | 2375 | 0.370 |
Why?
|
Myocardial Ischemia | 5 | 2011 | 2164 | 0.360 |
Why?
|
Seasons | 10 | 2011 | 1522 | 0.350 |
Why?
|
Cardiovascular Diseases | 15 | 2012 | 15760 | 0.340 |
Why?
|
Coronary Disease | 7 | 2012 | 5991 | 0.340 |
Why?
|
Weather | 4 | 2011 | 226 | 0.330 |
Why?
|
Soot | 1 | 2011 | 221 | 0.330 |
Why?
|
Temperature | 7 | 2011 | 2221 | 0.320 |
Why?
|
Genome-Wide Association Study | 23 | 2012 | 12628 | 0.320 |
Why?
|
Heart Conduction System | 2 | 2012 | 1015 | 0.310 |
Why?
|
Regression Analysis | 13 | 2011 | 6359 | 0.300 |
Why?
|
Cities | 6 | 2011 | 538 | 0.300 |
Why?
|
von Willebrand Factor | 3 | 2010 | 673 | 0.290 |
Why?
|
Aged | 74 | 2012 | 169143 | 0.280 |
Why?
|
Long QT Syndrome | 2 | 2011 | 466 | 0.280 |
Why?
|
Disease | 1 | 2011 | 671 | 0.260 |
Why?
|
Leukocyte Count | 1 | 2010 | 1599 | 0.260 |
Why?
|
Physical Exertion | 1 | 2008 | 662 | 0.250 |
Why?
|
Aerosols | 5 | 2011 | 632 | 0.240 |
Why?
|
Electrocardiography | 10 | 2012 | 6415 | 0.240 |
Why?
|
Poisson Distribution | 5 | 2011 | 507 | 0.240 |
Why?
|
Middle Aged | 73 | 2012 | 220359 | 0.230 |
Why?
|
Haplotypes | 10 | 2012 | 2764 | 0.230 |
Why?
|
Tachycardia, Supraventricular | 1 | 2006 | 274 | 0.230 |
Why?
|
Coronary Artery Disease | 5 | 2011 | 6659 | 0.220 |
Why?
|
Blood Coagulation | 4 | 2011 | 1157 | 0.220 |
Why?
|
Dyspnea | 1 | 2011 | 1353 | 0.220 |
Why?
|
Carbon Monoxide | 5 | 2010 | 541 | 0.210 |
Why?
|
Motor Vehicles | 1 | 2004 | 281 | 0.210 |
Why?
|
Nitrogen Dioxide | 6 | 2011 | 512 | 0.200 |
Why?
|
Public Health | 4 | 2011 | 2653 | 0.200 |
Why?
|
Heart Diseases | 5 | 2011 | 2809 | 0.200 |
Why?
|
Hazardous Substances | 1 | 2002 | 152 | 0.190 |
Why?
|
Respiration Disorders | 1 | 2005 | 368 | 0.190 |
Why?
|
Male | 78 | 2012 | 359718 | 0.190 |
Why?
|
Cross-Over Studies | 4 | 2011 | 2061 | 0.190 |
Why?
|
Humans | 110 | 2012 | 760613 | 0.180 |
Why?
|
Diabetes Mellitus, Type 2 | 11 | 2012 | 12289 | 0.170 |
Why?
|
Risk Assessment | 14 | 2011 | 24102 | 0.170 |
Why?
|
Multigene Family | 4 | 2011 | 1077 | 0.170 |
Why?
|
Nanoparticles | 1 | 2011 | 1943 | 0.170 |
Why?
|
Thromboplastin | 2 | 2011 | 286 | 0.160 |
Why?
|
1-Alkyl-2-acetylglycerophosphocholine Esterase | 2 | 2011 | 129 | 0.160 |
Why?
|
Meteorological Concepts | 2 | 2009 | 31 | 0.160 |
Why?
|
Pulmonary Disease, Chronic Obstructive | 2 | 2011 | 3226 | 0.160 |
Why?
|
Genetic Loci | 4 | 2011 | 2618 | 0.150 |
Why?
|
Tachycardia, Ventricular | 1 | 2006 | 1303 | 0.150 |
Why?
|
Genotype | 11 | 2012 | 12957 | 0.140 |
Why?
|
Prediabetic State | 3 | 2012 | 550 | 0.140 |
Why?
|
Female | 68 | 2012 | 391246 | 0.140 |
Why?
|
Chromosome Mapping | 5 | 2012 | 4626 | 0.140 |
Why?
|
Adult | 48 | 2012 | 220007 | 0.140 |
Why?
|
Sulfur Dioxide | 4 | 2011 | 177 | 0.130 |
Why?
|
Interleukin-1 | 2 | 2010 | 1249 | 0.130 |
Why?
|
Dust | 2 | 2010 | 483 | 0.120 |
Why?
|
Epidemiologic Studies | 3 | 2011 | 670 | 0.120 |
Why?
|
Gene Frequency | 6 | 2012 | 3613 | 0.120 |
Why?
|
Risk Factors | 25 | 2012 | 74333 | 0.120 |
Why?
|
Metabolome | 2 | 2011 | 982 | 0.120 |
Why?
|
Longitudinal Studies | 9 | 2011 | 14494 | 0.120 |
Why?
|
Chromosomes, Human, Pair 1 | 3 | 2011 | 635 | 0.120 |
Why?
|
Time Factors | 11 | 2011 | 40139 | 0.110 |
Why?
|
Adrenergic beta-Antagonists | 2 | 2011 | 1259 | 0.110 |
Why?
|
Comorbidity | 7 | 2012 | 10553 | 0.110 |
Why?
|
Sickness Impact Profile | 2 | 2011 | 298 | 0.110 |
Why?
|
Inflammation | 7 | 2011 | 10755 | 0.110 |
Why?
|
China | 4 | 2011 | 2339 | 0.110 |
Why?
|
Aged, 80 and over | 21 | 2012 | 58980 | 0.110 |
Why?
|
Europe | 6 | 2009 | 3441 | 0.100 |
Why?
|
Leisure Activities | 2 | 2011 | 306 | 0.100 |
Why?
|
Quantitative Trait Loci | 2 | 2012 | 2101 | 0.100 |
Why?
|
Case-Control Studies | 10 | 2012 | 22052 | 0.100 |
Why?
|
Eukaryotic Initiation Factor-4G | 1 | 2012 | 67 | 0.100 |
Why?
|
Death Certificates | 2 | 2010 | 167 | 0.100 |
Why?
|
Interleukin 1 Receptor Antagonist Protein | 2 | 2010 | 298 | 0.100 |
Why?
|
Fibrin Fibrinogen Degradation Products | 2 | 2011 | 418 | 0.100 |
Why?
|
Genetic Predisposition to Disease | 11 | 2012 | 17790 | 0.100 |
Why?
|
Fasting | 3 | 2012 | 1603 | 0.090 |
Why?
|
Electrocardiography, Ambulatory | 3 | 2011 | 578 | 0.090 |
Why?
|
Potassium Channels, Voltage-Gated | 1 | 2011 | 141 | 0.090 |
Why?
|
Motor Activity | 2 | 2011 | 2688 | 0.090 |
Why?
|
Cohort Studies | 18 | 2012 | 41337 | 0.090 |
Why?
|
Atmosphere | 1 | 2010 | 32 | 0.090 |
Why?
|
Logistic Models | 5 | 2011 | 13312 | 0.090 |
Why?
|
Triterpenes | 1 | 2011 | 81 | 0.090 |
Why?
|
Torsades de Pointes | 1 | 2011 | 79 | 0.090 |
Why?
|
Overweight | 2 | 2012 | 2421 | 0.090 |
Why?
|
Serum Amyloid A Protein | 1 | 2010 | 127 | 0.090 |
Why?
|
Factor V | 1 | 2011 | 168 | 0.090 |
Why?
|
Blood Chemical Analysis | 1 | 2012 | 437 | 0.090 |
Why?
|
Exercise Test | 3 | 2008 | 2128 | 0.090 |
Why?
|
Lung Diseases | 2 | 2011 | 1915 | 0.090 |
Why?
|
Cause of Death | 2 | 2011 | 3725 | 0.090 |
Why?
|
Serum | 1 | 2011 | 211 | 0.090 |
Why?
|
Sensitivity and Specificity | 3 | 2011 | 14661 | 0.090 |
Why?
|
Geography | 2 | 2011 | 661 | 0.090 |
Why?
|
Atrial Natriuretic Factor | 1 | 2011 | 350 | 0.090 |
Why?
|
Factor VII | 1 | 2010 | 139 | 0.090 |
Why?
|
Oxidants, Photochemical | 1 | 2010 | 76 | 0.080 |
Why?
|
Odds Ratio | 4 | 2012 | 9716 | 0.080 |
Why?
|
Climate | 1 | 2010 | 147 | 0.080 |
Why?
|
Duffy Blood-Group System | 1 | 2009 | 60 | 0.080 |
Why?
|
Blood Pressure | 4 | 2011 | 8525 | 0.080 |
Why?
|
Chloride Channels | 1 | 2011 | 221 | 0.080 |
Why?
|
Methylenetetrahydrofolate Reductase (NADPH2) | 1 | 2011 | 275 | 0.080 |
Why?
|
Chromosomes, Human, Pair 11 | 1 | 2010 | 410 | 0.080 |
Why?
|
Chromosomes, Human, Pair 4 | 1 | 2010 | 377 | 0.080 |
Why?
|
Promoter Regions, Genetic | 3 | 2009 | 5782 | 0.080 |
Why?
|
Sex Characteristics | 2 | 2011 | 2629 | 0.080 |
Why?
|
Blood Glucose | 3 | 2012 | 6379 | 0.080 |
Why?
|
Genetic Variation | 5 | 2012 | 6552 | 0.080 |
Why?
|
Arm | 1 | 2012 | 583 | 0.080 |
Why?
|
Epidemiology | 1 | 2011 | 278 | 0.080 |
Why?
|
Intercellular Adhesion Molecule-1 | 2 | 2010 | 1126 | 0.080 |
Why?
|
Prospective Studies | 11 | 2012 | 54306 | 0.080 |
Why?
|
Gene Expression Regulation | 1 | 2007 | 11902 | 0.080 |
Why?
|
Menarche | 1 | 2011 | 529 | 0.080 |
Why?
|
Amidohydrolases | 1 | 2009 | 162 | 0.080 |
Why?
|
Vesicular Transport Proteins | 1 | 2011 | 374 | 0.080 |
Why?
|
Polymorphism, Genetic | 2 | 2009 | 4286 | 0.080 |
Why?
|
Arachidonate 15-Lipoxygenase | 1 | 2008 | 84 | 0.080 |
Why?
|
Wind | 1 | 2008 | 41 | 0.080 |
Why?
|
Lipoproteins, LDL | 1 | 2011 | 641 | 0.080 |
Why?
|
Peroxidase | 1 | 2011 | 605 | 0.080 |
Why?
|
Sphingolipids | 1 | 2009 | 173 | 0.080 |
Why?
|
Chromosomes, Human, Pair 3 | 1 | 2009 | 315 | 0.080 |
Why?
|
Plasma | 1 | 2011 | 584 | 0.070 |
Why?
|
Metabolic Networks and Pathways | 1 | 2012 | 788 | 0.070 |
Why?
|
Hypertension | 5 | 2012 | 8595 | 0.070 |
Why?
|
Factor VIII | 1 | 2010 | 350 | 0.070 |
Why?
|
Lymphocyte Count | 1 | 2010 | 780 | 0.070 |
Why?
|
Parkinson Disease | 2 | 2012 | 2859 | 0.070 |
Why?
|
Body Mass Index | 8 | 2012 | 12914 | 0.070 |
Why?
|
ABO Blood-Group System | 1 | 2010 | 369 | 0.070 |
Why?
|
Cold Temperature | 1 | 2011 | 780 | 0.070 |
Why?
|
P-Selectin | 1 | 2010 | 599 | 0.070 |
Why?
|
Anti-Arrhythmia Agents | 1 | 2011 | 784 | 0.070 |
Why?
|
Chemokine CCL2 | 1 | 2009 | 605 | 0.070 |
Why?
|
Homozygote | 2 | 2009 | 1788 | 0.070 |
Why?
|
Periodicity | 1 | 2008 | 348 | 0.070 |
Why?
|
Registries | 5 | 2011 | 8458 | 0.070 |
Why?
|
Environmental Health | 1 | 2009 | 284 | 0.070 |
Why?
|
Lipoproteins | 1 | 2011 | 882 | 0.070 |
Why?
|
Chromosomes, Human | 1 | 2008 | 442 | 0.070 |
Why?
|
Nitrous Oxide | 1 | 2006 | 166 | 0.070 |
Why?
|
Metabolomics | 2 | 2012 | 1628 | 0.060 |
Why?
|
Quality Control | 1 | 2008 | 828 | 0.060 |
Why?
|
Corneal Diseases | 1 | 2011 | 536 | 0.060 |
Why?
|
Oxidative Stress | 3 | 2011 | 3106 | 0.060 |
Why?
|
Cataract | 1 | 2011 | 827 | 0.060 |
Why?
|
Rest | 1 | 2010 | 914 | 0.060 |
Why?
|
Retinal Diseases | 1 | 2011 | 702 | 0.060 |
Why?
|
Carbon | 2 | 2008 | 669 | 0.060 |
Why?
|
American Heart Association | 1 | 2010 | 1081 | 0.060 |
Why?
|
Antigen Presentation | 1 | 2010 | 1254 | 0.060 |
Why?
|
Respiratory Function Tests | 1 | 2010 | 1683 | 0.060 |
Why?
|
Phenotype | 6 | 2012 | 16548 | 0.060 |
Why?
|
Spectrum Analysis | 1 | 2006 | 453 | 0.060 |
Why?
|
Hot Temperature | 1 | 2011 | 1435 | 0.060 |
Why?
|
Cerebrovascular Disorders | 1 | 2011 | 1501 | 0.060 |
Why?
|
Endothelium, Vascular | 2 | 2008 | 4434 | 0.060 |
Why?
|
Netherlands | 3 | 2005 | 2213 | 0.060 |
Why?
|
Genetic Markers | 4 | 2012 | 2609 | 0.060 |
Why?
|
Glucose Tolerance Test | 3 | 2012 | 1174 | 0.060 |
Why?
|
DNA | 2 | 2008 | 7233 | 0.060 |
Why?
|
Body Height | 1 | 2010 | 1570 | 0.060 |
Why?
|
Tobacco Smoke Pollution | 1 | 2010 | 812 | 0.060 |
Why?
|
Chest Pain | 1 | 2011 | 1106 | 0.060 |
Why?
|
Fatigue | 1 | 2011 | 1544 | 0.060 |
Why?
|
Death, Sudden, Cardiac | 1 | 2012 | 1572 | 0.060 |
Why?
|
Rabbits | 1 | 2010 | 4773 | 0.050 |
Why?
|
Linear Models | 2 | 2011 | 5877 | 0.050 |
Why?
|
Body Composition | 1 | 2012 | 2419 | 0.050 |
Why?
|
Time | 1 | 2004 | 545 | 0.050 |
Why?
|
Confidence Intervals | 1 | 2008 | 2932 | 0.050 |
Why?
|
Geriatric Assessment | 1 | 2010 | 1405 | 0.050 |
Why?
|
Cost of Illness | 1 | 2012 | 1940 | 0.050 |
Why?
|
Natriuretic Peptide, Brain | 1 | 2011 | 1716 | 0.050 |
Why?
|
Autonomic Nervous System Diseases | 1 | 2005 | 269 | 0.050 |
Why?
|
Mutation, Missense | 1 | 2011 | 2567 | 0.050 |
Why?
|
Homeostasis | 2 | 2010 | 3306 | 0.050 |
Why?
|
Glaucoma | 1 | 2011 | 1182 | 0.050 |
Why?
|
Atrial Fibrillation | 2 | 2010 | 5209 | 0.050 |
Why?
|
Quality of Life | 3 | 2012 | 13308 | 0.050 |
Why?
|
Inflammation Mediators | 2 | 2009 | 1881 | 0.050 |
Why?
|
Lung | 3 | 2011 | 9994 | 0.050 |
Why?
|
Myocardium | 2 | 2011 | 4700 | 0.050 |
Why?
|
Blood Platelets | 2 | 2010 | 2519 | 0.050 |
Why?
|
Monocytes | 1 | 2010 | 2575 | 0.050 |
Why?
|
Antihypertensive Agents | 1 | 2011 | 2061 | 0.050 |
Why?
|
Nitric Oxide | 2 | 2008 | 2141 | 0.050 |
Why?
|
Diagnostic Errors | 1 | 2008 | 1266 | 0.050 |
Why?
|
Sex Factors | 4 | 2011 | 10546 | 0.050 |
Why?
|
Population | 2 | 2012 | 140 | 0.050 |
Why?
|
Models, Genetic | 4 | 2012 | 3442 | 0.050 |
Why?
|
Urban Population | 1 | 2009 | 2022 | 0.050 |
Why?
|
Autonomic Nervous System | 1 | 2005 | 697 | 0.040 |
Why?
|
Receptors, Cell Surface | 1 | 2009 | 2825 | 0.040 |
Why?
|
Heart | 2 | 2010 | 4393 | 0.040 |
Why?
|
Adipose Tissue | 1 | 2012 | 3300 | 0.040 |
Why?
|
Activities of Daily Living | 2 | 2010 | 2417 | 0.040 |
Why?
|
Genome, Human | 2 | 2010 | 4418 | 0.040 |
Why?
|
Social Class | 1 | 2009 | 2005 | 0.040 |
Why?
|
Body Weight | 1 | 2010 | 4611 | 0.040 |
Why?
|
Models, Statistical | 3 | 2009 | 5075 | 0.040 |
Why?
|
Life Style | 1 | 2011 | 3898 | 0.040 |
Why?
|
Age Factors | 4 | 2012 | 18413 | 0.040 |
Why?
|
Finland | 3 | 2005 | 603 | 0.040 |
Why?
|
Health Care Costs | 1 | 2011 | 3258 | 0.040 |
Why?
|
Pedigree | 3 | 2011 | 4578 | 0.040 |
Why?
|
Models, Biological | 3 | 2012 | 9468 | 0.040 |
Why?
|
Vitamin D | 1 | 2011 | 3291 | 0.040 |
Why?
|
Glucose | 1 | 2009 | 4350 | 0.040 |
Why?
|
Markov Chains | 2 | 2011 | 968 | 0.040 |
Why?
|
Diabetes Mellitus | 3 | 2012 | 5890 | 0.040 |
Why?
|
Disease Susceptibility | 1 | 2004 | 1792 | 0.040 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 3 | 2010 | 3802 | 0.030 |
Why?
|
Likelihood Functions | 2 | 2011 | 987 | 0.030 |
Why?
|
Chronic Disease | 1 | 2011 | 9288 | 0.030 |
Why?
|
Smoking | 2 | 2010 | 9073 | 0.030 |
Why?
|
Mental Health | 1 | 2010 | 3213 | 0.030 |
Why?
|
Life Expectancy | 1 | 2002 | 1247 | 0.030 |
Why?
|
Self Report | 3 | 2011 | 3711 | 0.030 |
Why?
|
Humidity | 2 | 2009 | 205 | 0.030 |
Why?
|
Reproducibility of Results | 5 | 2012 | 20080 | 0.030 |
Why?
|
Meta-Analysis as Topic | 2 | 2010 | 1376 | 0.030 |
Why?
|
Alleles | 3 | 2011 | 6900 | 0.030 |
Why?
|
Obesity | 3 | 2012 | 12919 | 0.030 |
Why?
|
Atherosclerosis | 1 | 2011 | 3518 | 0.030 |
Why?
|
Hospitalization | 2 | 2011 | 10789 | 0.030 |
Why?
|
Exercise | 1 | 2010 | 5787 | 0.030 |
Why?
|
Delivery of Health Care | 1 | 2011 | 5325 | 0.030 |
Why?
|
Ozone | 2 | 2008 | 477 | 0.030 |
Why?
|
Health Status Indicators | 2 | 2009 | 968 | 0.030 |
Why?
|
Socioeconomic Factors | 2 | 2008 | 7805 | 0.030 |
Why?
|
Animals | 6 | 2012 | 167960 | 0.030 |
Why?
|
trans-Golgi Network | 1 | 2011 | 33 | 0.020 |
Why?
|
Erythrocytes | 2 | 2012 | 2415 | 0.020 |
Why?
|
Osmolar Concentration | 1 | 2012 | 660 | 0.020 |
Why?
|
Patient Readmission | 1 | 2005 | 3322 | 0.020 |
Why?
|
Aging | 1 | 2010 | 8652 | 0.020 |
Why?
|
Hydrogen Bonding | 1 | 2011 | 291 | 0.020 |
Why?
|
Rats, Inbred SHR | 1 | 2010 | 186 | 0.020 |
Why?
|
Acute-Phase Reaction | 1 | 2010 | 91 | 0.020 |
Why?
|
Health Surveys | 2 | 2012 | 4063 | 0.020 |
Why?
|
Population Groups | 1 | 2011 | 211 | 0.020 |
Why?
|
Base Pairing | 1 | 2010 | 140 | 0.020 |
Why?
|
Carnitine | 1 | 2011 | 251 | 0.020 |
Why?
|
Follow-Up Studies | 4 | 2012 | 39262 | 0.020 |
Why?
|
Cross-Sectional Studies | 4 | 2012 | 25941 | 0.020 |
Why?
|
Injections, Spinal | 1 | 2010 | 316 | 0.020 |
Why?
|
Prevalence | 3 | 2012 | 15686 | 0.020 |
Why?
|
Work | 1 | 2010 | 194 | 0.020 |
Why?
|
Interleukin-1alpha | 1 | 2009 | 86 | 0.020 |
Why?
|
Young Adult | 6 | 2011 | 58748 | 0.020 |
Why?
|
Air | 1 | 2009 | 186 | 0.020 |
Why?
|
Glutathione Transferase | 1 | 2010 | 565 | 0.020 |
Why?
|
Data Collection | 2 | 2011 | 3315 | 0.020 |
Why?
|
Receptors, Interleukin-1 | 1 | 2009 | 261 | 0.020 |
Why?
|
Endosomes | 1 | 2011 | 519 | 0.020 |
Why?
|
Cardiovascular Physiological Phenomena | 1 | 2010 | 239 | 0.020 |
Why?
|
Thrombin | 1 | 2011 | 593 | 0.020 |
Why?
|
Diabetic Neuropathies | 1 | 2012 | 406 | 0.020 |
Why?
|
Risk | 2 | 2010 | 9632 | 0.020 |
Why?
|
Vital Capacity | 1 | 2011 | 965 | 0.020 |
Why?
|
Hepatocyte Nuclear Factor 1-alpha | 1 | 2009 | 169 | 0.020 |
Why?
|
Glycine | 1 | 2011 | 662 | 0.020 |
Why?
|
Endpoint Determination | 1 | 2011 | 597 | 0.020 |
Why?
|
Spirometry | 1 | 2011 | 924 | 0.020 |
Why?
|
North Carolina | 1 | 2008 | 325 | 0.020 |
Why?
|
Body Size | 1 | 2010 | 462 | 0.020 |
Why?
|
Soil | 1 | 2008 | 109 | 0.020 |
Why?
|
Health Status | 2 | 2011 | 4082 | 0.020 |
Why?
|
Potassium | 1 | 2011 | 1313 | 0.020 |
Why?
|
Fluorescence | 1 | 2010 | 751 | 0.020 |
Why?
|
Office Visits | 1 | 2011 | 597 | 0.020 |
Why?
|
Anthropometry | 1 | 2012 | 1348 | 0.020 |
Why?
|
Hemostasis | 1 | 2010 | 468 | 0.020 |
Why?
|
Blood Pressure Determination | 1 | 2011 | 640 | 0.020 |
Why?
|
Amino Acid Substitution | 1 | 2011 | 1737 | 0.020 |
Why?
|
Antigen-Presenting Cells | 1 | 2010 | 967 | 0.020 |
Why?
|
Sulfates | 1 | 2008 | 379 | 0.020 |
Why?
|
Area Under Curve | 1 | 2011 | 1635 | 0.020 |
Why?
|
Cell Size | 1 | 2008 | 624 | 0.020 |
Why?
|
Genetic Linkage | 1 | 2012 | 2381 | 0.020 |
Why?
|
Genetics, Population | 1 | 2011 | 929 | 0.020 |
Why?
|
Blood Proteins | 1 | 2012 | 1173 | 0.020 |
Why?
|
Protein Precursors | 1 | 2011 | 1134 | 0.020 |
Why?
|
Proportional Hazards Models | 2 | 2011 | 12531 | 0.020 |
Why?
|
Organic Chemicals | 1 | 2007 | 211 | 0.020 |
Why?
|
Eye Diseases | 1 | 2012 | 651 | 0.020 |
Why?
|
Waist Circumference | 1 | 2010 | 926 | 0.020 |
Why?
|
Exons | 1 | 2012 | 2389 | 0.020 |
Why?
|
Hormones | 1 | 2010 | 867 | 0.020 |
Why?
|
Forced Expiratory Volume | 1 | 2011 | 1809 | 0.020 |
Why?
|
Monte Carlo Method | 1 | 2011 | 1257 | 0.020 |
Why?
|
Age Distribution | 1 | 2011 | 2893 | 0.020 |
Why?
|
Drug Utilization | 1 | 2011 | 1195 | 0.020 |
Why?
|
History, 18th Century | 1 | 2005 | 207 | 0.020 |
Why?
|
Amino Acids | 1 | 2011 | 1714 | 0.020 |
Why?
|
Thrombosis | 2 | 2010 | 3051 | 0.020 |
Why?
|
Chi-Square Distribution | 1 | 2011 | 3465 | 0.020 |
Why?
|
Neoplasms | 2 | 2011 | 22075 | 0.020 |
Why?
|
International Normalized Ratio | 1 | 2006 | 387 | 0.020 |
Why?
|
E-Selectin | 1 | 2006 | 576 | 0.010 |
Why?
|
Age of Onset | 1 | 2011 | 3302 | 0.010 |
Why?
|
Employment | 1 | 2010 | 1112 | 0.010 |
Why?
|
Macrophages | 2 | 2009 | 5745 | 0.010 |
Why?
|
Educational Status | 1 | 2011 | 2514 | 0.010 |
Why?
|
Reference Values | 1 | 2011 | 4925 | 0.010 |
Why?
|
Interleukin-1beta | 1 | 2009 | 999 | 0.010 |
Why?
|
Linkage Disequilibrium | 1 | 2008 | 1996 | 0.010 |
Why?
|
ras Proteins | 1 | 2009 | 1051 | 0.010 |
Why?
|
Protein Conformation | 1 | 2011 | 3970 | 0.010 |
Why?
|
Drug Costs | 1 | 2011 | 1185 | 0.010 |
Why?
|
Lipid Metabolism | 1 | 2011 | 1902 | 0.010 |
Why?
|
United States Environmental Protection Agency | 1 | 2003 | 139 | 0.010 |
Why?
|
United States | 3 | 2010 | 72448 | 0.010 |
Why?
|
Longevity | 1 | 2010 | 1050 | 0.010 |
Why?
|
Insulin-Secreting Cells | 1 | 2009 | 907 | 0.010 |
Why?
|
Psychiatric Status Rating Scales | 1 | 2012 | 6015 | 0.010 |
Why?
|
Heterozygote | 1 | 2008 | 2798 | 0.010 |
Why?
|
Cardiovascular System | 1 | 2009 | 850 | 0.010 |
Why?
|
Up-Regulation | 1 | 2010 | 4122 | 0.010 |
Why?
|
Angina Pectoris | 1 | 2005 | 969 | 0.010 |
Why?
|
Magnetic Resonance Spectroscopy | 1 | 2011 | 3765 | 0.010 |
Why?
|
Reactive Oxygen Species | 1 | 2009 | 2138 | 0.010 |
Why?
|
Ambulatory Care | 1 | 2011 | 2782 | 0.010 |
Why?
|
Lipids | 1 | 2011 | 3336 | 0.010 |
Why?
|
Social Support | 1 | 2010 | 2145 | 0.010 |
Why?
|
Antigens, CD | 1 | 2010 | 4000 | 0.010 |
Why?
|
Population Surveillance | 1 | 2010 | 2608 | 0.010 |
Why?
|
Molecular Sequence Data | 1 | 2012 | 17624 | 0.010 |
Why?
|
Evidence-Based Medicine | 1 | 2011 | 3696 | 0.010 |
Why?
|
Research Support as Topic | 1 | 2003 | 699 | 0.010 |
Why?
|
Tumor Necrosis Factor-alpha | 1 | 2010 | 4356 | 0.010 |
Why?
|
Data Interpretation, Statistical | 1 | 2008 | 2696 | 0.010 |
Why?
|
Adolescent | 3 | 2012 | 87809 | 0.010 |
Why?
|
Ventricular Dysfunction, Left | 1 | 2009 | 2128 | 0.010 |
Why?
|
Neutrophils | 1 | 2010 | 3767 | 0.010 |
Why?
|
Genetic Testing | 1 | 2011 | 3531 | 0.010 |
Why?
|
Software | 1 | 2012 | 4419 | 0.010 |
Why?
|
Insulin | 1 | 2012 | 6596 | 0.010 |
Why?
|
Proteins | 1 | 2012 | 6029 | 0.010 |
Why?
|
Insulin Resistance | 1 | 2010 | 3959 | 0.010 |
Why?
|
Biomedical Research | 1 | 2011 | 3426 | 0.010 |
Why?
|
Research Design | 1 | 2011 | 6180 | 0.010 |
Why?
|
Predictive Value of Tests | 1 | 2011 | 15286 | 0.010 |
Why?
|
Research | 1 | 2003 | 1974 | 0.010 |
Why?
|
Rats | 1 | 2010 | 23709 | 0.010 |
Why?
|
Severity of Illness Index | 1 | 2011 | 15840 | 0.010 |
Why?
|
Databases, Factual | 1 | 2008 | 8022 | 0.010 |
Why?
|
Mental Disorders | 1 | 2012 | 6796 | 0.010 |
Why?
|
Emergency Service, Hospital | 1 | 2010 | 7818 | 0.010 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2003 | 10826 | 0.010 |
Why?
|
Stroke | 1 | 2012 | 9952 | 0.010 |
Why?
|
Mutation | 1 | 2012 | 29957 | 0.000 |
Why?
|
Mice | 1 | 2012 | 81209 | 0.000 |
Why?
|
Treatment Outcome | 1 | 2011 | 64981 | 0.000 |
Why?
|